 | • レポートコード：MRC2212B045 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、232ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査資料では、2021年に509.3億ドルであった世界の整形外科用インプラント市場規模が、2022年に537.1億ドルに達し、2027年には707.9億ドルまで年平均5.64%で成長すると予測しています。当書は、整形外科用インプラントの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、生体材料別（セラミック生体材料、金属系生体材料、高分子生体材料）分析、種類別（足首、歯科、股関節、膝、その他）分析、製品タイプ別（歯科用インプラント、矯正生物学、人工関節置換術、脊椎インプラント、外傷用インプラント）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめております。なお、当書には、Aequos Endoprothetik GmbH、Amplitude SAS、Argomedical AG、Arthrex, Inc.、Bioimpianti Group srl、Biotech GmbH、Biotechni、C2F Implants、Ceraver、CONMED Corporation、Corin Group PLC、DJO Finance LLC、Globus Medical Inc.、Groupe Lepineなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の整形外科用インプラント市場規模：生体材料別 - セラミック生体材料の市場規模 - 金属系生体材料の市場規模 - 高分子生体材料の市場規模 ・世界の整形外科用インプラント市場規模：種類別 - 足首の市場規模 - 歯科の市場規模 - 股関節の市場規模 - 膝の市場規模 - その他種類の市場規模 ・世界の整形外科用インプラント市場規模：製品タイプ別 - 歯科用インプラントの市場規模 - 矯正生物学の市場規模 - 人工関節置換術の市場規模 - 脊椎インプラントの市場規模 - 外傷用インプラントの市場規模 ・世界の整形外科用インプラント市場規模：地域別 - 南北アメリカの整形外科用インプラント市場規模 アメリカの整形外科用インプラント市場規模 カナダの整形外科用インプラント市場規模 ブラジルの整形外科用インプラント市場規模 ... - アジア太平洋の整形外科用インプラント市場規模 日本の整形外科用インプラント市場規模 中国の整形外科用インプラント市場規模 インドの整形外科用インプラント市場規模 韓国の整形外科用インプラント市場規模 台湾の整形外科用インプラント市場規模 ... - ヨーロッパ/中東/アフリカの整形外科用インプラント市場規模 イギリスの整形外科用インプラント市場規模 ドイツの整形外科用インプラント市場規模 インドの整形外科用インプラント市場規模 フランスの整形外科用インプラント市場規模 ロシアの整形外科用インプラント市場規模 ... - その他地域の整形外科用インプラント市場規模 ・競争状況 ・企業情報 |
The Global Orthopedic Implants Market size was estimated at USD 50.93 billion in 2021 and expected to reach USD 53.71 billion in 2022, and is projected to grow at a CAGR 5.64% to reach USD 70.79 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Orthopedic Implants to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Bio-material, the market was studied across Ceramic Biomaterials, Metallic Biomaterials, and Polymeric Biomaterials. The Metallic Biomaterials is further studied across Cobalt Alloy, Stainless steel, and Titanium Alloy.
Based on Type, the market was studied across Ankle, Dental, Hip, Knee, Spine, and Wrist & Shoulder.
Based on Product Type, the market was studied across Dental Implants, Orthobiologics, Reconstructive Joint Replacements, Spinal Implants, and Trauma. The Dental Implants is further studied across Plate Form Dental Implants and Root Form Dental Implants. The Orthobiologics is further studied across Allograft, Bone Morphogenetic Protein, Demineralized Bone Matrix, Synthetic Bone Substitutes, and Viscosupplementation Products. The Reconstructive Joint Replacements is further studied across Extremities, Hip Replacement Implants, and Knee Replacement Implants. The Spinal Implants is further studied across Motion Preservation Devices/Non-Fusion Devices, Spinal Fusion Devices, and Vertebral Compression Fracture Devices. The Motion Preservation Devices/Non-Fusion Devices is further studied across Annulus Repair Devices, Artificial Disc Replacement Devices, Dynamic Stabilization Devices, and Nuclear Disc Prostheses. The Spinal Fusion Devices is further studied across Cervical Fixation Devices, Interbody Fusion Devices, and Thoracolumbar Devices. The Vertebral Compression Fracture Devices is further studied across Balloon Kyphoplasty Devices and Vertebroplasty Devices.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Orthopedic Implants market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Orthopedic Implants Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Orthopedic Implants Market, including Aequos Endoprothetik GmbH, Amplitude SAS, Argomedical AG, Arthrex, Inc., Bioimpianti Group srl, Biotech GmbH, Biotechni, C2F Implants, Ceraver, CONMED Corporation, Corin Group PLC, DJO Finance LLC, Globus Medical Inc., Groupe Lepine, Hipokrat A.S, Implants International Limited, Johnson & Johnson, Lima Corporate S.p.a., Mathys AG Bettlach, Medtronic Plc, Peter Brehm GmbH, Sanatmetal Ltd., Serf Dedienne sant, Smith and Nephew Plc., Stanmore Implants Worldwide Ltd., Stryker Corporation, Symbios Orthopdie SA, Waldemar Link GmbH & Co. KG, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Orthopedic Implants Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Orthopedic Implants Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Orthopedic Implants Market?
4. What is the competitive strategic window for opportunities in the Global Orthopedic Implants Market?
5. What are the technology trends and regulatory frameworks in the Global Orthopedic Implants Market?
6. What is the market share of the leading vendors in the Global Orthopedic Implants Market?
7. What modes and strategic moves are considered suitable for entering the Global Orthopedic Implants Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in prevalence of orthopedic disorders and awareness about the treatment,
5.1.1.2. Technology advancements in the treatment of musculoskeletal disorders
5.1.1.3. Need for faster recovery, minimum pain, and cost-effective treatments
5.1.2. Restraints
5.1.2.1. Incidence of product recalls due to device inefficiency or manufacturing errors
5.1.3. Opportunities
5.1.3.1. Potential in the emerging economies due to improved healthcare facilities
5.1.3.2. Favorable government initiatives to increase participation in sports leading to a high incidence of injuries
5.1.4. Challenges
5.1.4.1. Stringent FDA regulations approving the entry of new players
5.2. Cumulative Impact of COVID-19
6. Orthopedic Implants Market, by Bio-material
6.1. Introduction
6.2. Ceramic Biomaterials
6.3. Metallic Biomaterials
6.4.1. Cobalt Alloy
6.4.2. Stainless steel
6.4.3. Titanium Alloy
6.4. Polymeric Biomaterials
7. Orthopedic Implants Market, by Type
7.1. Introduction
7.2. Ankle
7.3. Dental
7.4. Hip
7.5. Knee
7.6. Spine
7.7. Wrist & Shoulder
8. Orthopedic Implants Market, by Product Type
8.1. Introduction
8.2. Dental Implants
8.3.1. Plate Form Dental Implants
8.3.2. Root Form Dental Implants
8.3. Orthobiologics
8.4.1. Allograft
8.4.2. Bone Morphogenetic Protein
8.4.3. Demineralized Bone Matrix
8.4.4. Synthetic Bone Substitutes
8.4.5. Viscosupplementation Products
8.4. Reconstructive Joint Replacements
8.5.1. Extremities
8.5.2. Hip Replacement Implants
8.5.3. Knee Replacement Implants
8.5. Spinal Implants
8.6.1. Motion Preservation Devices/Non-Fusion Devices
8.6.2.1. Annulus Repair Devices
8.6.2.2. Artificial Disc Replacement Devices
8.6.2.3. Dynamic Stabilization Devices
8.6.2.4. Nuclear Disc Prostheses
8.6.2. Spinal Fusion Devices
8.6.3.1. Cervical Fixation Devices
8.6.3.2. Interbody Fusion Devices
8.6.3.3. Thoracolumbar Devices
8.6.3. Vertebral Compression Fracture Devices
8.6.4.1. Balloon Kyphoplasty Devices
8.6.4.2. Vertebroplasty Devices
8.6. Trauma
9. Americas Orthopedic Implants Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Orthopedic Implants Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Orthopedic Implants Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Aequos Endoprothetik GmbH
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Amplitude SAS
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Argomedical AG
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Arthrex, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Bioimpianti Group srl
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Biotech GmbH
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Biotechni
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. C2F Implants
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Ceraver
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. CONMED Corporation
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Corin Group PLC
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. DJO Finance LLC
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Globus Medical Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Groupe Lepine
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Hipokrat A.S
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Implants International Limited
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Johnson & Johnson
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Lima Corporate S.p.a.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Mathys AG Bettlach
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Medtronic Plc
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Peter Brehm GmbH
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Sanatmetal Ltd.
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Serf Dedienne sant
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Smith and Nephew Plc.
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Stanmore Implants Worldwide Ltd.
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. Stryker Corporation
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services
13.27. Symbios Orthopdie SA
13.27.1. Business Overview
13.27.2. Key Executives
13.27.3. Product & Services
13.28. Waldemar Link GmbH & Co. KG
13.28.1. Business Overview
13.28.2. Key Executives
13.28.3. Product & Services
13.29. Wright Medical Group N.V.
13.29.1. Business Overview
13.29.2. Key Executives
13.29.3. Product & Services
13.30. Zimmer Biomet Holdings, Inc.
13.30.1. Business Overview
13.30.2. Key Executives
13.30.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing